ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

CA Stem Cell Agency Chief Randy Mills to Leave After Three Years … – Xconomy

Continue reading

2017-05-02 Michael Zand NEWS

Researchers Publish Two New Methods for Analysis of CRISPR Off-Target Effects – GenomeWeb


Sacramento Bee

CA Stem Cell Agency Chief Randy Mills to Leave After Three Years …
Xconomy
The head of California’s stem-cell agency is stepping down after three years on the job. C. Randall Mills, known as Randy, is leaving the agency to run a n.
CIRM — California’s stem cell research funding agency — to lose …San Francisco Business Times
California stem cell agency president steps down as worries mount …Sacramento Bee

all 3 news articles »

Continue reading

2017-05-02 Michael Zand NEWS

Researchers Publish Two New Methods for Analysis of CRISPR Off-Target Effects – GenomeWeb

Researchers Publish Two New Methods for Analysis of CRISPR Off-Target Effects
GenomeWeb
NEW YORK (GenomeWeb) – Two studies published simultaneously in Nature Methods yesterday describe new methods for analyzing the off-target effects of CRISPR/Cas-9 genome editing. One method identifies off-target mutations associated with …

Continue reading

2017-05-02 Michael Zand NEWS

California stem cell agency boss finds new job – San Francisco Business Times

Researchers Publish Two New Methods for Analysis of CRISPR Off-Target Effects
GenomeWeb
NEW YORK (GenomeWeb) – Two studies published simultaneously in Nature Methods yesterday describe new methods for analyzing the off-target effects of CRISPR/Cas-9 genome editing. One method identifies off-target mutations associated with …

Continue reading

2017-05-02 Michael Zand NEWS

Breakthrough for stem cell transplant patients – The Hippocratic Post (blog)

The Hippocratic Post (blog)Breakthrough for stem cell transplant patientsThe Hippocratic Post (blog)Stem cell transplants have been in use for decades as a cure for blood cancer and blood disorders. Approximately 2,000 people need a transplant in the … Continue reading

2017-05-02 Michael Zand NEWS

Oncologists Often Favor Immunotherapy Over NGS-Guided Targeted Drugs, Survey Finds – GenomeWeb

Oncologists Often Favor Immunotherapy Over NGS-Guided Targeted Drugs, Survey FindsGenomeWebA sampling of more than 100 physicians showed that more than two-thirds preferred prescribing patients a type of immunotherapy, called a checkpoint inhibitor, ra… Continue reading

2017-05-02 Michael Zand NEWS

Unproven stem cell therapies – promise versus evidence – BioNews

California stem cell agency boss finds new job
San Francisco Business Times
Randy Mills, who came in to right California’s semi-public stem cell research funding agency, is leaving to head the National Marrow Donor Program. Mills three years ago came in as CEO of the California Institute for Regenerative Medicine with an eye …

Continue reading

2017-05-02 Michael Zand NEWS

The CRISPR patent dispute – Europe and the US – BioNews

The CRISPR patent dispute – Europe and the USBioNewsThe CRISPR-Cas9 genome editing system finds its scientific roots in the observation that prokaryotes utilise CRISPR to identify and destroy viruses. Professor Jennifer Doudna of UC and Professor Emman… Continue reading

2017-05-02 Michael Zand NEWS
  • 1
  • …
  • 1,775
  • 1,776
  • 1,777
  • 1,778
  • 1,779
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

The Oracle Dispatch

Unproven stem cell therapies – promise versus evidence
BioNews
The ability of stem cells to divide into different mature cell types has ignited the field of regenerative medicine. Stem cells promise to repair and regenerate damaged or diseased tissues without the need for orthodox medical or surgical interventions …
US Stem Cell Inc (OTCMKTS:USRM) Explodes Higher Ahead of RMAT DecisionThe Oracle Dispatch
US Stem Cell Inc (OTCMKTS:USRM) Extends Rise After Private Equity Firm Commits to Share PurchaseStreet Register
US Stem Cell Inc (OTCMKTS:USRM) Receives Institutional Fund InjectionStockNewsUnion
Lenox Ledger
all 5 news articles »